Advance Next
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.advancenext.netRevenue
<$5 MillionIndustry
About Advance Next
Is Advance Next your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Advance Next had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Advance Next has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Advance Next launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Advance Next
Earning: See what the market has to say on Advance Next recently announced quarterly report
Check out if Advance Next is spiking on competitors!
Advance Next, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Advance Next has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Advance Next
Compare insights from companies similar to Advance Next, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Advance Next
Company Profile Activity
Activity Insights
Advance Next is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Advance Next is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Advance Next.
Advance Next Tech Stack
A closer look at the technologies used by Advance Next
Advance Next News & Media
Hebe Biotechnology Appoints Industry Insider Dr. Hannes Hentze as Chief Development Officer to Advance Next-Generation GLP-1 RA Weight Loss Therapy
SINGAPORE, Apr 10, 2025 - (ACN Newswire) - April 9, Hebe Biotechnology Pte Ltd (“Hebe Bio”), a Singapore-based innovator in metabolic health therapeutics, today announced the appointment of Hannes Hentze, PhD, MBA as Chief Development Officer (CDO), effective April 1, 2025. Dr. Hentze will lead the global development strategy for the company’s next-generation GLP-1 receptor agonist (GLP-1 RA), a cutting-edge weight loss therapy designed to enhance efficacy and tolerability, addressing the global
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advance Next
Advance Next | Web Site Development & Design | Indianapolis, Indiana | Greenwood, Indiana | Columbus, Indiana | Franklin, Indiana Advance Next logo Advance Next A part logo Advance Next next part logo arrow up icon arrow swipe icon facebook google plus linked in twitter... Read More